Skip to main content
Signal8

Collins Cynthia

SEC insider (Form 3/4/5 filer). CIK 0001405692. Director at MAXCYTE, INC. (MXCT) and 3 other issuers. 14 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in REDWOOD CITY, CA.

Companies Collins Cynthia has filed insider reports for

  • MAXCYTE, INC. (MXCT): Director
  • CODEXIS, INC. (CDXS): Director
  • Certara, Inc. (CERT): Director
  • Poseida Therapeutics, Inc. (PSTX): Director
Collins Cynthia profile photo

Collins Cynthia

CIK: 0001405692

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (14.3%)

Derivative conversions

Awards (A)7 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)5 (35.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (4)

MAXCYTE, INC. logo
MXCT

MAXCYTE, INC.

Director
CODEXIS, INC. logo
CDXS

CODEXIS, INC.

Director
Certara, Inc. logo
CERT

Certara, Inc.

Director
Poseida Therapeutics, Inc. logo
PSTX

Poseida Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (14 total)

  • MAXCYTE, INC. logo
    MXCT

    MAXCYTE, INC.

    Jun 17, 2026
    Award
    Direct
    30.4K shares-
  • CODEXIS, INC. logo
    CDXS

    CODEXIS, INC.

    Jun 17, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    66.4K shares-
  • Certara, Inc. logo
    CERT

    Certara, Inc.

    May 14, 2026
    Exercise
    Direct
    15.8K shares-
  • MAXCYTE, INC. logo
    MXCT

    MAXCYTE, INC.

    Jun 18, 2025
    Award
    Direct
    29.2K shares-
  • CODEXIS, INC. logo
    CDXS

    CODEXIS, INC.

    Jun 10, 2025
    Award
    Direct
    41K shares-
  • Certara, Inc. logo
    CERT

    Certara, Inc.

    May 21, 2025
    Exercise
    Direct
    11.9K shares-
  • Certara, Inc. logo
    CERT

    Certara, Inc.

    May 21, 2025
    Award

    Restricted Stock Units

    Direct
    15.8K shares-
  • CODEXIS, INC. logo
    CDXS

    CODEXIS, INC.

    Mar 28, 2025
    Award
    Direct
    71.2K shares-
  • Poseida Therapeutics, Inc. logo
    PSTX

    Poseida Therapeutics, Inc.

    Jan 8, 2025
    Tender Offer
    Direct
    59K shares-
  • Poseida Therapeutics, Inc. logo
    PSTX

    Poseida Therapeutics, Inc.

    Jan 8, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    87.4K shares-

1-10 of 14